Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's disease

Sebastiaan Ten Bokkel Huinink, Vince Biemans, Marjolijn Duijvestein, Marieke Pierik, Frank Hoentjen, Rachel L. West, Christien J. van der Woude, Annemarie C. de Vries

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's disease'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science